Inflammatory Responses Not Yet Recruiting Phase 1 Trials for Digoxin (DB00390)

Also known as: Inflammatory Response

IndicationStatusPhase
DBCOND0062877 (Inflammatory Responses)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03559868Effect of Digoxin on PKM2 Binding to Pro-inflammatory Loci and Innate Immune Inflammatory Responses in the Peripheral Blood.Prevention